Baxter International Inc. appears well-positioned to weather the COVID-19 pandemic.
On 30 April, the company reported that the surge in COVID-19 patients increased demand for products from five of its...
Baxter Reports $45M Boost From COVID-19 Demand In Q1
The COVID-19 pandemic has increased demand for products from all of Baxter’s businesses except its advanced surgery division. Overall, the diversified company’s global sales were up 8% in the first quarter.
